Skip to main content
Latest Update
2026-11-17 04:06 UTC

Isomorphic Labs secures $5B to accelerate AI drug design

Isomorphic Labs secures $5B to accelerate AI drug design

According to a post by Demis Hassabis on X, Isomorphic Labs raised $5B to advance AI-driven, first-principles drug design aimed at cutting time and cost in new medicine discovery.

Source

Analysis

On November 17 2026 Demis Hassabis announced five billion dollars in funding for IsomorphicLabs to speed up its mission of solving disease through artificial intelligence according to the post.

The company is advancing AI systems that redesign drug discovery from first principles to shorten development timelines and lower costs for new medicines.

Demis Hassabis

@demishassabis

Nobel Laureate and DeepMind CEO pursuing AGI development while transforming drug discovery at Isomorphic Labs.